This trial is withdrawn!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Second Degree Burn Less Than 5%TBSA or Partial Thickness Burn
and you are
over 18
years old
1
2
This is a medium phase trial determining
the safety and dosage of the new treatment, as well as its efficacy.
Show me locations

The purpose

The objective of this Trial is to evaluate the performance of RPh201 as a treatment for the healing of partial thickness burns. It is further postulated that deep second degree lesions will benefit from the RPh201 treatment promoting granulation and epithelialization as well as wound closure.

Provided treatments

  • Drug: RPh201, botanical drug product

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01455480. The sponsor of the trial is Regenera Pharma Ltd and it is looking for 0 volunteers for the current phase.
Official trial title:
Trial To Evaluate RPh201 In Treatment Of Partial Thickness Burn